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Abstract The extracellular proteolytic pathway mediated by 
the urokinase plasminogen activator (uPA) is a cascade system, 
initiated by activation of the zymogen, pro-uPA. Pro-uPA as 
well as uPA binds to the cellular uPA receptor (uPAR) which has 
a central function in cell-dependent acceleration of the cascade 
system. This role of uPAR is generally assumed to be a 
positioning effect since uPAR-expressing cells exclusively 
stimulate the activation of cell surface-bound plasminogen (Ellis 
et al. (1993) Methods Enzymol. 223, 223-233). However, it was 
recently reported that a recombinant, soluble uPAR (suPAR) 
was capable of accelerating plasminogen activation in solution 
(Higazi et al. (1995) J. Biol. Chem. 270, 17375-17380). In this 
work we show that suPAR as such has no accelerative role. In 
contrast, the progress of the activation reactions in a soluble 
system with pro-uPA and plasminogen was found to be 
attenuated by suPAR. This delay of the activation system was 
shown to include a partial inhibition of the plasmin-mediated 
activation of pro-uPA as well as of the uPA-mediated activation 
of plasminogen. 
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1. Introduction 
Urokinase plasminogen activator (uPA) is a serine pro- 
tease which specifically converts the inactive zymogen, plas- 
minogen, into active plasmin. Through this function, uPA 
plays an important role in a number of extracellular proteo- 
lytic processes which involve plasmin activity, notably in the 
context of tissue remodeling phenomena occurring in certain 
normal physiological conditions as well as in cancer invasion 
[11. 
The active uPA molecule merges by proteolytic activation 
of the single-chain pro-enzyme, pro-uPA, which has very low 
intrinsic proteolytic activity [2]. While several proteases have 
been shown to activate pro-uPA in vitro [2-9], the physiolo- 
gical initiation mechanism for this system is still unknown. 
However, as soon as the first plasmin molecules are formed, 
a strong feed-back mechanism, mediated by plasmin-catalyzed 
activation of pro-uPA, leads to a dramatic amplification of 
the activation system (see [2,10] for a discussion). For this 
reason, in in vitro experiments with mixtures of pro-uPA 
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and plasminogen, increasingly rapid activation of both zymo- 
gens proceeds once the system is initiated, e.g., by trace 
amounts of one of the active enzymes. 
Both pro-uPA and active uPA bind to the cellular uPA 
receptor (uPAR) [11,12] which participates in localizing and 
accelerating the cascade at the cell surface. Thus, in the pres- 
ence of pro-uPA a number of cell types are able to stimulate 
plasminogen activation and this acceleration can be abolished 
by uPAR-blocking reagents [13,14]. However, the molecular 
mechanism of this stimulatory function has not been clarified. 
The accelerative effect of uPAR-expressing cells is strictly de- 
pendent on the additional cellular binding of plasminogen 
[13], suggesting that the role of uPAR is mostly an orientation 
and concentration effect. In contradiction to this view it has 
been suggested that receptor-ligand binding as such augments 
the enzymatic properties of pro-uPA [15]. 
Recently, a stimulatory effect of a recombinant, soluble 
uPAR on the activation system in the liquid-phase was re- 
ported [16]. Due to the role of the uPA system in invasive 
processes the interference with plasminogen activation at the 
cell surface may have important herapeutic perspectives [17] 
and in this context, an accelerative effect caused directly by 
uPAR would be a central potential target. In order to study 
the functional role of uPAR at the molecular level, we have 
now investigated the influence of the purified receptor on the 
activation reactions which proceed in solution with different 
combinations of the pro-enzymes and active enzymes of the 
cascade. 
2. Materials and methods 
2.1. Purified proteins and protease substrates 
Recombinant, human soluble uPAR (suPAR) was isolated from the 
culture medium of transfected Chinese Hamster Ovary cells by im- 
munoafl]nity chromatography as described [18] and subsequently sub- 
jected to gel filtration on a Superdex 75 prep grade column (Pharma- 
cia Biotech, Uppsala, Sweden), using PBS as the eluent, for removal 
of trace amounts of IgG. Purified, recombinant human pro-uPA was 
a kind gift from Dr. P. Sarmientos, Farmitalia Carlo Erba, Milan, 
Italy. Human two-chain uPA was purchased from Serono, Aubonne, 
Switzerland. Purification of human Glu-plasminogen from fresh plas- 
ma of healthy donors and preparation of active plasmin were per- 
formed as described [19]. Purified bovine serum albumin (BSA) and 
purified ovalbumin were purchased from Behringwerke AG, Marburg, 
Germany and Sigma, St. Louis, MO, respectively. The amino-terminal 
fragment (ATF) of uPA, and the chromogenic substrate for plasmin, 
H-o-norleucyl-hexahydrotyrosyl-lysine-p-nitroanilide (Nle-HHT-Lys- 
pNA; Spectrozyme PL), were purchased from American Diagnostica 
Inc., Greenwich, CT. The chromogenic uPA substrate, e-pyrogluta- 
myl-glycyl-e-arginine-p-nitroanilide ( < Glu-Gly-Arg-pNA; $2444) 
was purchased from Chromogenics AB, M61ndal, Sweden. 
2.2. Protease activity assays 
Chromogenic assays were performed in the wells of microtitre 
plates [9] (Nunc, Roskilde, Denmark) in a total reaction volume of 
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200 ktl, All samples were tested in duplicate. Pro-enzymes, active en- 
zymes, other proteins and chromogenic peptide substrates were mixed 
as indicated and the substrate conversion was followed at 37°C by 
readings of the absorbance at 405 nm. The plasmin activity was ex- 
pressed as the rate of conversion of the substrate, NIe-HHT-Lys-pNA 
(AA4oJmin), measured at each time point indicated [20,21]. The ami- 
dolytic activity of uPA, resulting from conversion of pro-uPA, was 
measured in the same manner except hat the substrate, < Glu-Gly- 
Arg-pNA, was used [2]. 
3. Results 
3.1. Binding of  pro-uPA to purified suPAR attenuates 
plasminogen activation 
In order to study the function of receptor-bound pro-uPA 
in a cell-free system, we employed a recombinant, water-solu- 
ble uPAR variant (suPAR) which comprises all of the three 
extracellular domains of the receptor and which binds uPA 
with the same affinity as cell-bound uPAR [22,23]. Purified 
suPAR was added to mixtures of pro-uPA and Glu-plasmino- 
gen and the generation of plasmin was followed by the con- 
version of a chromogenic plasmin substrate (Fig. 1). Two 
parallel sets of samples were analyzed. In one series of sam- 
ples we included a carrier protein, BSA (0.5% w/v), in the 
buffer in order to prevent the problems of denaturation and 
surface adsorption usually encountered with dilute protein 
solutions. In another series, the samples were made up with- 
out carrier proteins in order to reproduce the conditions un- 
der which a stimulatory function of suPAR has been reported 
[161. 
This difference in conditions turned out to be critical for the 
outcome. In the carrier-containing samples, the addition of 
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Fig. 1. Effect of purified suPAR on a coupled activation system 
with pro-uPA and plasminogen. The assay was performed using 
PBS with 0.5% BSA as the solvent ((3, zx) or PBS only (e, A). 
Pro-uPA (2 nM) and Glu-plasminogen (1 p.M) were incubated with 
the chromogenic plasmin substrate, Nle-HHT-Lys-pNA (0.5 mM) in 
the absence (O, e) or presence (zx, • )  of suPAR (2 nM). The ab- 
sorbance at 405 nm was followed and the plasmin activity (ex- 
pressed as the substrate conversion rate; AA40Jmin) was plotted vs. 
time. Each point is the mean of a double determination. Parallel 
samples, prepared in the same manner but without pro-uPA, all had 
activities below 2x 10 -a AU/min throughout the assay. 
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Fig. 2. Effect of blocking suPAR against pro-uPA binding. Pro-uPA 
(5 nM) and Glu-plasrninogen (10 nM) were incubated with 0.5 mM 
of Nle-HHT-Lys-pNA, either alone (©) or in the presence of the 
following reagents: 5 nM of suPAR (zx), 50 nM of ATF (~2) or a 
pre-formed mixture of suPAR and ATF (final concentrations 5 and 
50 nM, respectively) (XT), The plasmin activity was plotted as de- 
scribed in the legend to Fig. 1. Each point is the mean of a double 
determination. (A) Results obtained using PBS with 0.5% BSA as 
the solvent. (B) Results obtained using PBS as the solvent without 
carrier proteins added. Note that under these conditions the genera- 
tion of active plasmin (slope of the curves) declines after 30~0 min, 
probably due to surface adsorption phenomena. 
A Fig. 3. Concentration dependence of suPAR. Pro-uPA (5 nM) and 
Glu-plasminogen (10 nM) were incubated with 0.5 mM of Nle- 
HHT-Lys-pNA in the absence of suPAR (O) or in the presence of 
the following concentrations of suPAR: 5 nM (zx), 25 nM (E]), 100 
nM (0). The plasmin activity was plotted as described in the legend 
to Fig. 1. Each point is the mean of a double determination. (A) 
The assay was performed using PBS with 0.5% BSA as the solvent. 
(B) The solvent was PBS only. In this case prolongation of the in- 
cubation period beyond 30~,0 min led to a decrease in the plasmin 
generation; see the legend to Fig. 2B. 
suPAR had no stimulatory effect on the activation system. 
Actually, a delayed progress of the cascade reaction was 
noted, relative to the samples without suPAR (Fig. 1, O, 
zx). The same result was found if another carrier protein, 
ovalbumin, was used instead of BSA (results not shown). In 
contrast, in the carrier-free system (Fig. 1, e, • ) ,  the samples 
containing the purified suPAR preparation showed a faster 
activation profile than the samples without suPAR. The latter 
result was thus in accordance with the results the results re- 
ported [16] but under these conditions, both in the presence 
and absence of suPAR, the progress of the activation system 
was slower than that observed in the BSA-containing samples. 
This observation was likely to reflect surface adsorption of 
part of the material; see also Figs. 2 and 3, below. 
The apparent discrepancy between the effects of suPAR 
addition found in the presence and absence of carriers could 
be explained if only one of the effects was caused by the pro- 
uPA-suPAR binding reaction per se, while other factors were 
responsible for the opposing effect. Therefore, it was necessary 
to test the specificity of the interactions further. Since the 
feed-back conversion of pro-uPA, mediated by the active plas- 
min generated, soon becomes a dominating factor under the 
conditions used above, we adjusted the conditions by decreas- 
ing the concentration of plasminogen 100-fold and increasing 
the pro-uPA concentration to 5 nM in order to analyze the 
early activation phase in more detail. Under these conditions, 
an inhibitory effect of suPAR was again observed in the pres- 
ence of the carrier protein while stimulation was found in the 
samples devoid of carrier (Fig. 2A and B, respectively; com- 
pare the curves represented by circles and triangles). Using 
this system, we studied the effect of blocking suPAR binding 
by means of the receptor-binding, amino-terminal fragment 
(ATF) of uPA which lacks the catalytic domain of the enzyme 
[24]. suPAR was pre-incubated with ATF and subsequently 
added to the mixtures of pro-uPA and plasminogen (Fig. 
2A,B, v). In the system with carrier proteins present, ATF 
blocked the inhibitory capacity of suPAR completely (Fig. 
2A), in accordance with the expected pattern for inhibition 
dependent on the binding of pro-uPA to suPAR. In contrast, 
ATF did not influence the stimulation of the cascade resulting 
from addition of suPAR to the carrier-free samples (Fig. 2B). 
The latter finding is contradictory to the results reported [16] 
and strongly suggests that the stimulatory effect, observed in 
these samples, was a result of events other than the binding 
reaction between suPAR and pro-uPA. 
The most obvious interfering factor would be the unavoid- 
able proteolytic initiation of the feed-back system, which 
would be caused by even minute amounts of contaminating 
proteases within the purified suPAR preparation. Such an 
effect would be expected to be most dominant in carrier-free 
samples; see Section 4. In the next experiment, we varied the 
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Fig. 4. Effect of suPAR on the reciprocal ctivation processes of the 
feed-back system. (A) Activation of pro-uPA, catalyzed by plasmin. 
Pro-uPA (10 nM) was incubated with the uPA substrate, <Glu- 
Gly-Arg-pNA (0.4 mM) and 100 ng/ml of plasmin in the absence 
(O) or presence (A) of suPAR (10 nM), or with the following con- 
centrations of plasmin in the absence of suPAR: 60 ng/ml (D) or 
40 ng/ml (0). The curve represented by inverted triangles (v) 
shows the result obtained with pro-uPA and chromogenic substrate 
alone. All samples were dissolved in PBS with 0.5% BSA. The uPA 
activity (A,440jmin) was plotted vs. time. Each point is the mean of 
a double determination. (B)Activation of plasminogen, catalyzed by 
active uPA. Glu-plasminogen (100 nM) was incubated with 0.5 mM 
of NIe-HHT-Lys-pNA and 0.25 nM of two-chain uPA in the ab- 
sence (O) or presence (A) of suPAR (2 nM), or with 0.20 nM of 
two-chain uPA in the absence of suPAR ([~). The curve represented 
by inverted triangles (v) shows the result obtained with plasmino- 
gen and chromogenic substrate alone. All samples were dissolved in 
PBS with 0.5% BSA. The plasmin activity was plotted vs. time. 
Each point is the mean of a double determination. 
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concentration of suPAR from equivalence to 20-fold excess, 
relative to pro-uPA (Fig. 3). It was clear that, in the carrier- 
free samples, the stimulatory effect was concentration depend- 
ent even when a large molar excess of suPAR was used (Fig. 
3B). Already at equivalence the suPAR concentration was 
about 10 times higher than the Kd of the interaction [10,23], 
implying that pro-uPA was largely saturated with suPAR in 
the whole concentration range employed. In the light of the 
concentration dependence observed, the stimulatory effect 
could therefore not be ascribed to binding of the added su- 
PAR to pro-uPA. On the other hand, the pattern observed 
was in complete accordance with a proteolytic effect, leading 
to concentration-dependent amplification of the activation 
system. 
In contrast, the moderate inhibitory effect of suPAR which 
was noted in the BSA-containing samples howed no dose 
dependence in the present concentration range (Fig. 3A). 
This observation was consistent with a true effect produced 
by receptor binding. 
3.2. suPAR inhibits the conversion of pro-uPA as well as 
plasminogen 
In addition to studies on the initial phase in the coupled 
activation system, we performed separate analyses of the two 
steps responsible for feed-back activation (Fig. 4). In the light 
of the findings described above, these studies were limited to 
carrier-containing systems. 
Samples of pro-uPA in the absence or presence of equimo- 
lar amounts of suPAR were subjected to activation with vary- 
ing amounts of active plasmin, and the formation of active 
uPA was followed by conversion of a chromogenic uPA sub- 
strate. The addition of suPAR led to a delay in pro-uPA 
activation (Fig. 4A). The activation profile obtained with 
100 ng/ml (1.1 nM) of plasmin in the presence of suPAR 
was compared to a series of curves obtained with lower con- 
centrations of plasmin in the absence of suPAR. The curves 
obtained with 40 and 60 ng/ml of plasmin, respectively, are 
included in Fig. 4A, showing that addition of suPAR led to 
an approx. 50% inhibition of the activation efficiency under 
these conditions. This inhibition was directed against pro-uPA 
activation and not against he activity of the generated uPA 
towards the chromogenic substrate since we found that su- 
PAR had no effect on the amidolytic activity of two-chain 
uPA with < Glu-Gly-Arg-pNA (results not shown). 
Likewise, we studied the activation of plasminogen with 
active (two-chain) uPA and the influence of suPAR on this 
process (Fig. 4B). A weak inhibition of the reaction was 
noted, leading to an activation curve identical to the curve 
obtained with a 20% lower amount of uPA in the absence 
of suPAR. In a similar reaction system with detergent-con- 
taining samples the inclusion of uPAR, isolated from mem- 
brane fractions of U937 cells, has been shown to yield a 3~ 
40% inhibition of plasminogen activation [25]. Thus, the use 
of suPAR instead of uPAR and the change in reaction con- 
ditions did not change the qualitative ffect of addition of 
receptor. 
4. Discussion 
In order to elucidate the functional consequences of su- 
PAR-binding to pro-uPA, we studied the proteolytic ascade 
under several experimental conditions. By using the condi- 
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tions reported to reveal a stimulatory function of suPAR [16], 
we could reproduce an apparently accelerative effect on the 
activation system with pro-uPA and plasminogen. In a paral- 
lel experimental setting, we chose to include albumin as a 
carrier protein in the samples since the conformation and 
aggregation state of the zymogens and enzymes under these 
conditions would be more likely to reflect the physiological 
state, as compared to carrier-free samples with a very low 
total protein concentration. Under these conditions, we found 
that the cascade was not stimulated by suPAR but was in 
contrast moderately attenuated. 
This discrepancy was not likely to reflect a gross difference 
in the receptor-ligand binding. Thus, BSA is conveniently 
used as a carrier protein that will fully allow the interaction 
between suPAR and pro-uPA, e.g., in ligand-binding assays 
[26], as well as in enzymatic studies with uPAR on U937 cells 
[20]. Furthermore, the result obtained with another carrier 
protein, ovalbumin, was identical to that obtained with 
BSA, thus excluding a specific effect of the identity of the 
carrier. Consequently, we employed two independent criteria 
to examine the relation between receptor-binding of pro-uPA 
and the effects observed, i.e., (1) the effect of blocking of 
suPAR with ATF and (2) the concentration dependence of 
suPAR. According to both of these criteria the delay of the 
activation reactions, observed in the carrier-containing sam- 
ples, was consistent with an effect of the binding of pro-uPA 
to suPAR. In contrast, neither criterion supported that this 
binding reaction could be responsible for the stimulatory ef- 
fect seen in the carrier-free system. 
Even though the interfering factor in the carrier-free system 
was not positively identified, the concentration dependence 
observed favored the assumption that contaminating pro- 
teases gave rise to cascade initiation under these conditions. 
This interpretation is supported by the reported observation 
[16] that preincubation of pro-uPA with suPAR enhances the 
apparent stimulatory effect of the latter. A proteolytic effect of 
this kind would be expected to be counteracted by carrier 
proteins since these proteins would act as competing sub- 
strates for proteolysis and would also reduce the aggregation 
of active proteases with the highly hydrophobic pro-uPA. In 
the coupled system, even an extremely small proteolytic effect 
at an early point would appear as a strong effect after feed- 
back amplification (see, e.g. [2] for experimental demonstra- 
tion of this phenomenon). It should be noted that this highly 
amplifying capacity is a major problem in any attempt o 
quantify the putative activity of pro-uPA in terms of initial 
reaction rates since these rates are likely to reflect he content 
of active enzymes from the start of analysis [2]. Furthermore, 
the shape of the curves observed in Figs. 2B and 3B suggests 
that surface adsorption phenomena in the microtitre wells 
represents an additional problem in the carrier-free system. 
We conclude that the functional consequence of binding of 
pro-uPA to suPAR is a moderate inhibition of the activation 
of pro-uPA as well as plasminogen, and that some inhibition 
likewise results when plasminogen activation is studied with 
active uPA bound to suPAR. The finding that inhibition is 
only partial, even when complex formation is total, points to 
an incomplete steric hindrance of the activation reactions, 
rather than a specific inhibition directed against an active 
enzymatic site. For this reason, these inhibitory phenomena 
may not be of profound physiological importance. The im- 
portant finding, in contrast, is that the present receptor does 
not by itself stimulate nzymatic activity. This finding is in 
line with the result that uPAR-expressing cells become unable 
to stimulate plasminogen activation if the binding of plasmi- 
nogen to the cell surface is prevented [13,25]. 
Together, these results support the view that the stimula- 
tory role of uPAR-expressing cells is caused by the steric 
organization of uPAR and plasminogen-binding molecules 
on the cell surface [27]. This property of the uPA cascade 
marks an important difference from the tissue-type plasmino- 
gen activator (tPA) system in which the binding of single- 
chain tPA to fibrin directly enhances the enzymatic activity 
of the single-chain enzyme, in addition to localizing the activ- 
ity (see, e.g. [28,29]). 
Studies on the mechanism responsible for accelerated plas- 
minogen activation on the cell surface are of crucial impor- 
tance for the understanding of extracellular proteolysis in the 
context of invasive processes [17]. As evident from the discus- 
sion above, important aspects of these studies will be the 
identification of additional components on the cell with which 
uPAR and the enzymes of the cascade interact, as well as 
specific steric features of the plasma membrane allowing the 
interplay of all of the components involved. 
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